Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-02-01
1996-11-19
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514278, A61K 31435, C07D47108
Patent
active
055763278
ABSTRACT:
The use of 3,7,9,9-tetrasubstituted 3-phenylsulfonyl-3,7-diazabicyclo[3.3.1]nonane compounds for treating cardiac arrhythmias in larger mammals, including humans; novel antiarrhythmically active 3,7,9,9-tetrasubstituted compounds corresponding to the general formula Ia ##STR1## in which R.sup.1 is an alkyl group having 1-6 carbon atoms or a cycloalkylalkyl group having 4-7 carbon atoms,
REFERENCES:
patent: 4906640 (1990-03-01), Schoen et al.
patent: 4983611 (1991-01-01), Schoen et al.
Chemical abstracts, vol. 113, No. 13, 1990, Abstract No. 115277q.
Brueckner Reinhard
Farjam Arman
Schoen Uwe
Ziegler Dieter
Kali-Chemie Pharma GmbH
Krass Frederick
LandOfFree
Treatment of heart rhythym disorders by administration of 3-phen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of heart rhythym disorders by administration of 3-phen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of heart rhythym disorders by administration of 3-phen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-541265